Details of the Drug Formulations

General Information of Drug (ID: DM1UV7F)

Drug Name
Baloxavir marboxil Drug Info
Synonyms UNII-505CXM6OHG; 505CXM6OHG; Xofluza (TN); Baloxavir marboxil [INN]; Baloxavir marboxil (JAN/INN); SCHEMBL20108731; EX-A1867; HY-109025; CS-0030527
Indication
Disease Entry ICD 11 Status REF
Influenza virus infection 1E30-1E32 Approved [1]
Cross-matching ID
PubChem CID
124081896
CAS Number
1985606-14-1
TTD ID
D0O5AG
INTEDE ID
DR0171
ACDINA ID
D00858

Full List of Drug Formulations Containing This Drug

Baloxavir Marboxil 40 mg/20 ml for suspension
Company Formulation ID FDA Description
A-S Medication Solutions; Genentech F24239 Colloidal Silicon Dioxide; Hypromellose; Maltitol; Mannitol; Povidone K25; Sodium Chloride; Strawberry Flavor; Sucralose; Talc
------------------------------------------------------------------------------------
Baloxavir Marboxil 40 mg tablet
Company Formulation ID FDA Description
A-S Medication Solutions; Genentech F24253 Croscarmellose Sodium; Hypromellose; Lactose Monohydrate; Microcrystalline Cellulose; Povidone; Sodium Stearyl Fumarate; Talc; Titanium Dioxide
------------------------------------------------------------------------------------
Baloxavir Marboxil 80 mg tablet
Company Formulation ID FDA Description
A-S Medication Solutions; Genentech F24254 Croscarmellose Sodium; Hypromellose; Lactose Monohydrate; Microcrystalline Cellulose; Povidone; Sodium Stearyl Fumarate; Talc; Titanium Dioxide
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.